Treating older adults with acute myeloid leukemia is complicated, as the risk-benefit analysis for intensive and non-intensive therapeutic approaches is shifted compared to that in younger adults, and treatment recommendations must align with patient goals of care, which are by definition individualized. ASH has developed clinical practice guidelines for treating newly diagnosed acute myeloid leukemia in older adults that are sensitive to these issues, with approaches defined for real-time conversations that occur between patient and provider. This webinar will highlight the guideline recommendations along with the underlying evidence and rationale for the recommendations.

In this webinar, you will:

• Review two case-based presentations on recommendations for the use of anticoagulation to prevent venous thromboembolism in acutely and critically ill patients with COVID-19
• Review the current evidence, research needs, and ASH plans to update the systematic reviews and recommendations

Educational Objectives:

• Determine the value of intensive and non-intensive chemotherapy in older adults with AML.
• For less-intensive therapy approaches, compare the safety and efficacy of monotherapy and combination.
• Determine the role of transfusions in palliative care and hospice settings